|
|
| (148 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | | | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | + | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| | + | *'''[[Clinical guidelines and advice]]''' |
| | | | |
| − | *'''[[Research tools]]'''
| |
| − | {{tp|p=32142596|t=2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS |pdf=|usr=}}
| |
| − | {{tp|p=32187834|t=2020. ..COVID19: Cytometry and the New Challenge for Global Health |pdf=|usr=}}
| |
| − | {{tp|p=32270412|t=ä. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2 |pdf=|usr=}}
| |
| | | | |
| − | *
| |
| − | *'''[[Structure of covid19]]'''
| |
| | | | |
| − | *'''[[Target binding and uptake]]''' | + | *'''[[Respiration mgmt]]''' |
| − | {{tp|p=32220422|t=2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections |pdf=|usr=}}
| + | |
| − | {{tp|p=32336612|t=ä. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32210742|t=2020. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32327200|t=ä. Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Diagnosis (Laboratory)]]''' |
| | | | |
| | | | |
| | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | + | |
| | + | *'''[[Diagnosis (other modalities)]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | *'''[[Structure of covid19]]''' |
| | + | |
| | + | |
| | + | *'''[[Target binding and uptake]]''' |
| | *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| − | {{tp|p=32271376|t=ä. Factors associated with prolonged viral RNA shedding in patients with COVID-19 |pdf=|usr=}}
| + | |
| | + | |
| | | | |
| | *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
| | + | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=32348472|t=ä. A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?|pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| | | | |
| | | | |
| − | *'''[[Microvascular]]''' | + | |
| − | * | + | *'''[[Pathobiology]]''' |
| | + | |
| | + | |
| | + | *'''[[Disease Models]]''' |
| | + | |
| | + | |
| | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | *'''[[Early symptoms]]''' | | *'''[[Early symptoms]]''' |
| − | {{tp|p=32371463|t=2020. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis |pdf=|usr=}}
| |
| | | | |
| | *'''[[Systemic disease, any manifestations]]''' | | *'''[[Systemic disease, any manifestations]]''' |
| − | {{tp|p=32368495|t=2020. Co-infection with SARS-CoV-2 and influenza A virus |pdf=|usr=}}
| |
| − | {{tp|p=32368493|t=2020. Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report |pdf=|usr=}}
| |
| − | {{tp|p=32317036|t=ä. Bacterial and fungal infections in COVID-19 patients: A matter of concern |pdf=|usr=}}
| |
| | | | |
| | *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
| | | | |
| − | *'''[[ARDS]]'''
| |
| − | {{tp|p=32153144|t=2020. COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis |pdf=|usr=}}
| |
| − | {{tp|p=32342675|t=2020. COVID-19, A and Hypersensitivity Pneumonitis |pdf=|usr=}}
| |
| | | | |
| | *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| | + | |
| | + | |
| | + | |
| | | | |
| | | | |
| | *'''[[Hematology]]''' | | *'''[[Hematology]]''' |
| − | {{tp|p=32342677|t=2020. Severe Thrombocytopenia in a Patient with COVID-19 |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Heart]]'''
| |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]'''
| |
| | | | |
| − | *'''[[Dermatology]]''' | + | *'''[[Heart]]''' |
| | | | |
| − | *'''[[Gastroenterology, hepatology]]'''
| |
| − | {{tp|p=32188528|t=ä. SARS-CoV-2 enterocolitis with persisting to excrete the virus for approximately two weeks after recovering from diarrhea: A case report |pdf=|usr=}}
| |
| − | {{tp|p=32252855|t=ä. Alert for SARS-CoV-2 infection caused by fecal aerosols in rural areas in China |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Kidney, urology]]== | + | *'''[[Neurology, ophthalmology, orl]]''' |
| − | {{tp|p=32299479|t=2020. Acute kidney injury in SARS-CoV-2 infected patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32197060|t=2020. Rhabdomyolysis as Potential Late Complication Associated with COVID-19 |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *
| |
| − | *'''[[Pathobiology]]'''
| |
| − | {{tp|p=32317509|t=2020. COVID-19 and lung pathology |pdf=|usr=}}
| |
| − | {{tp|p=32345362|t=2020. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues |pdf=|usr=}}
| |
| − | {{tp|p=32333601|t=ä. Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Dermatology]]''' |
| | | | |
| − | *'''[[Disease Models]]'''
| |
| − | {{tp|p=32215622|t=ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility |pdf=|usr=}}
| |
| − | {{tp|p=32378471|t=2020. Animal models for emerging coronavirus: progress and new insights |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]''' | + | *'''[[Gastroenterology, hepatology]]''' |
| − | {{tp|p=31859605|t=2020. Genetic manipulation of porcine deltacoronavirus reveals insights into NS6 and NS7 functions: a novel strategy for vaccine design |pdf=|usr=}}
| + | |
| − | {{tp|p=32186278|t=2020. Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32142938|t=2020. Nonstructural proteins NS7b and NS8 are likely to be phylogenetically associated with evolution of 2019-nCoV |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Kidney, urology]]''' |
| | | | |
| − | *
| + | *'''[[The morbid survivor]]''' |
| − | *'''[[Diagnosis (Laboratory)]]''' | + | |
| | | | |
| | + | *'''[[Risk and special populations]]''' |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]'''
| |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]'''
| |
| − | {{tp|p=32276598|t=2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Respiration mgmt]]''' | + | *'''[[Case reports]]''' |
| | + | |
| | | | |
| | | | |
| − | *'''[[Clinical guidelines and advice]]'''
| |
| | | | |
| − | *'''[[Risk and special populations]]'''
| |
| | | | |
| − | *'''[[Case reports]]'''
| |
| | | | |
| | | | |
| Zeile 111: |
Zeile 100: |
| | | | |
| | | | |
| − | *'''[[The morbid survivor]]''' | + | *'''[[Registries]]''' |
| − | | + | |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − | {{tp|p=C7102592|t=ä. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID) |pdf=|usr=}}
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| | | | |
| − | *'''[[Biophysics of aerosols]]'''
| |
| | | | |
| | *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
| | + | |
| | + | |
| | + | *'''[[Biophysics of aerosols]]''' |
| | + | |
| | + | |
| | + | |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| | + | |
| | + | |
| | + | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | *'''[[Mental aspects of health professionals]]'''
| |
| | | | |
| | + | |
| | + | *'''[[Mental aspects of health professionals]]''' |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| | + | |
| | + | |
| | + | |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| | + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| − | {{tp|p=32341630|t=2020. Tackling Corona Virus Disease 2019 (COVID 19) in Workplaces |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − |
| |
| | | | |
| | | | |
| | *'''[[Educational aspects of the status hygienicus]]''' | | *'''[[Educational aspects of the status hygienicus]]''' |
| − | *
| + | ---- |
| | + | |
| | + | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| | + | |
| | + | *'''[[Epidemiology]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | | | |
| | *'''[[Remission, recurrence and persistence]]''' | | *'''[[Remission, recurrence and persistence]]''' |
| − | {{tp|p=32183934|t=2020. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020 |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Epidemiology]]'''
| + | |
| − | *'''[[Failure of politics and public health guidance]]'''
| + | |
| − | {{tp|p=32363133|t=ä. The Inadequacy of Regulatory Frameworks in Time of Crisis and in Low-Resource Settings: Personal Protective Equipment and COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32241306|t=ä. Harmonizing the COVID-19 cacophony: People need guidance |pdf=|usr=}}
| + | |
| − | {{tp|p=32143519|t=2020. Prediction of Epidemic Spread of the 2019 Novel Coronavirus Driven by Spring Festival Transportation in China: A Population-Based Study |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | + | ---- |
| | + | *'''[[Failure of politics and public health guidance]]''' |
| | + | |
| | + | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| − | {{tp|p=32358774|t=ä. On the death of 100?+?Italian doctors from COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32226292|t=2020. Tribute to health workers in China: A group of respectable population during the outbreak of the COVID-19 |pdf=|usr=}}
| |
| | | | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| − | {{tp|p=32345850|t=2020. Collateral damage of the COVID-19 outbreak: expression of concern |pdf=|usr=}}
| |
| | | | |
| − | *'''[[History of covid19 exploration]]'''
| + | ---- |
| − | {{tp|p=32235575|t=2020. The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Current state of coviki.org]]''' | + | |
| − | *[[PubMed selected papers unsorted to be listed in contents topics]]
| + | *'''[[History of covid19 exploration]]''' |
| − | *[[coviki state of development]]
| + | |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32319220|t=2020. Covid-19 and Namaste |pdf=|usr=}} | + | |
| | + | |
| | + | *'''[[Research tools]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | + | |
| | + | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[http://www.okaybio.com covid19 antibodies, proteins & reagents] | + | |
| − | *[http://www.reactionbiology.com 700 kinsse assays] | + | *'''[[Current state of coviki.org]]''' |
| − | *[http://www.neuroindx.com tissue microdissection device]
| + | *'''[[on-topic personal thoughts]]''' |
